EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is a paper indexed in PICO Portal from OpenAlex.
How many citations does EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype have?
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has 389 citations in the OpenAlex counts PICO Portal stores.
When was EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype published?
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has 2014 year in the PICO Portal index.
What is the open-access status of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype has closed oa status in the PICO Portal index.
What is the DOI of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?
The DOI for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.
What is the PMID of EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?
The PMID for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.
What is the OpenAlex record for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype?
The OpenAlex for EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype is on the source record.